Fig. 6
From: Repeated CyberKnife stereotactic body radiation therapy in hepatocellular carcinoma

There was no significant difference in OS between the interval time < 12 months group and in the interval time ≥ 12 months (p = 0.913)
From: Repeated CyberKnife stereotactic body radiation therapy in hepatocellular carcinoma
There was no significant difference in OS between the interval time < 12 months group and in the interval time ≥ 12 months (p = 0.913)